Impact Factor 2024

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

New approved drugs for psoriatic arthritis

F.M. Perrotta, E. Lubrano

57-64

09-09-2016

https://doi.org/10.4081/reumatismo.2016.873

3183

PDF: 2242
Long-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a single center

S. Casigliani Rabl, A. Della Rossa, P. Pepe, A. D'Ascanio, M. Mosca, A. Di Vita, S. Bombardieri

158-165

19-07-2012

https://doi.org/10.4081/reumatismo.2012.158

1084

PDF: 869
Far infrared emitting plaster in knee osteoarthritis: a single blinded, randomised clinical trial

GL. Bagnato, G. Miceli, M. Atteritano, N. Marino, GF. Bagnato

388-394

20-12-2012

https://doi.org/10.4081/reumatismo.2012.388

4465

PDF: 2414
Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

278-285

17-03-2014

https://doi.org/10.4081/reumatismo.2013.682

2703

PDF: 1395
Adherence to therapeutic and diagnostic recommendations in patients with femur fracture and at risk of re-fracture or death: results of an analysis of administrative databases

L. Degli Esposti, L. Sinigaglia, M. Rossini, S. Adami, C. Cagnoni, C. Magliaro, C. Veronesi, S. Buda, S. Minisola

18-26

16-03-2012

https://doi.org/10.4081/reumatismo.2012.18

1689

PDF: 975
The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study

M. Manara, L. Arcarese, G. Bianchi, V. Corbelli, O. Epis, R. Laurenti, A. Migliore, M. Muratore, A. Roncaglione, M. Rossini, M. Savo, L. Sinigaglia

188-194

31-12-2016

https://doi.org/10.4081/reumatismo.2016.903

1862

PDF: 958
A case of mandible Paget’s disease of the bone treated with intravenous neridronate

A. Fassio, L. Idolazzi, M. Rossini, O. Viapiana, D. Gatti

154-158

16-12-2016

https://doi.org/10.4081/reumatismo.2016.917

2125

PDF: 1082
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study

M. Rossini, O. Viapiana, M. Vitiello, N. Malavolta, G. La Montagna, S. Maddali Bongi, O. Di Munno, R. Nuti, C.U. Manzini, C. Ferri, L. Bogliolo, A. Mathieu, F. Cantatore, A. Del Puente, M. Muratore, W. Grassi, B. Frediani, G. Saviola, P. Delvino, L. Mirone, G. Ferraccioli, G. Tripi, I. Piazza, D. Gatti

30-39

22-05-2017

https://doi.org/10.4081/reumatismo.2017.922

4607

PDF: 3096
Manual therapy and therapeutic exercise in the treatment of osteoarthritis of the hip: a systematic review

A. Romeo, S. Parazza, M. Boschi, T. Nava, C. Vanti

63-74

27-05-2013

https://doi.org/10.4081/reumatismo.2013.63

7408

PDF: 3898
Bone mineral density in women on long-term mud-bath therapy in a Salus per Aquam (SPA) environment

A. Loi, S. Lisci, A. Denotti, A. Cauli

121-125

24-07-2013

https://doi.org/10.4081/reumatismo.2013.121

2919

PDF: 1056
Short story of antirheumatic therapy.VIII. The immunodepressants

G. Pasero, P. Marson

44-54

19-03-2012

https://doi.org/10.4081/reumatismo.2012.44

1587

PDF: 1489
Three-dimensional morphological condylar and mandibular changes in a patient with juvenile idiopathic arthritis: interdisciplinary treatment

G. Farronato, C. Bellintani, U. Garagiola, P. Cressoni, P. Sarzi Puttini, F. Atzeni, M. Cazzola

254-257

06-11-2014

https://doi.org/10.4081/reumatismo.2014.725

2553

PDF: 1339
Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature

M. Varenna, F. Bertoldo, M. Di Monaco, A. Giusti, G. Martini, M. Rossini, On behalf of SIOMMMS, Endorsed by SIR

143-166

31-10-2013

https://doi.org/10.4081/reumatismo.2013.143

7160

PDF: 2624
The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature

S. Barsotti, E. Cioffi, A. Tripoli, A. Tavoni, A. d’Ascanio, M. Mosca, R. Neri

78-84

06-07-2018

https://doi.org/10.4081/reumatismo.2018.1011

2608

PDF: 1381
Possible relationship between certolizumab pegol and arrhythmias: report of two cases

R. Talotta, F. Atzeni, A. Batticciotto, D. Ventura, P. Sarzi-Puttini

104-108

09-09-2016

https://doi.org/10.4081/reumatismo.2016.869

1663

PDF: 984
Work-related carpal tunnel syndrome treatment: a cross-sectional study among 106 patients

M. Aouatef, B. Asma, H. Hajer, A. Charfeddine, B. Lamia, K. Taoufik

59-64

03-08-2017

https://doi.org/10.4081/reumatismo.2017.978

2698

PDF: 1259
Update on treatment of polymyalgia rheumatica

D. Camellino, C. Dejaco

59-66

27-03-2018

https://doi.org/10.4081/reumatismo.2018.1062

5906

PDF: 3419
Prevention and treatment of glucocorticoid-induced osteoporosis in International and Italian scenarios

O. Di Munno, A. Delle Sedie

67-79

https://doi.org/10.4081/reumatismo.2011.67

1604

PDF: 977
Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre

A. Bortoluzzi, M. Padovan, I. Farina, E. Galuppi, F. De Leonardis, M. Govoni

350-359

20-12-2012

https://doi.org/10.4081/reumatismo.2012.350

3131

PDF: 2677
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs

F.M. Perrotta, O. Addimanda, R. Ramonda, S. D’Angelo, E. Lubrano, A. Marchesoni, I. Olivieri, L. Punzi, C. Salvarani, A. Spadaro

208-214

06-11-2014

https://doi.org/10.4081/reumatismo.2014.756

2690

PDF: 1506
IgA deficiency evidence after anti-TNF-α treatment in a psoriatic arthritis patient: case report

S. Iervolino, M. Lofrano, M.N.D. Di Minno, F. Foglia, R. Scarpa, R. Peluso

40-43

19-03-2012

https://doi.org/10.4081/reumatismo.2012.40

995

PDF: 1562
Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs

E. Lubrano, R. Scarpa

107-112

05-06-2012

https://doi.org/10.4081/reumatismo.2012.107

1412

PDF: 1232
Endothelin receptor antagonists: effects on extracellular matrix synthesis in primary cultures of skin fibroblasts from systemic sclerosis patients

S. Soldano, P. Montagna, R. Brizzolara, C. Ferrone, A. Parodio, A. Sulli, B. Seriolo, B. Villaggio, M. Cutolo

326-334

11-12-2012

https://doi.org/10.4081/reumatismo.2012.326

1755

PDF: 856
Duration of treatment for osteoporosis

Luca Idolazzi, A. Fassio, D. Gatti, S. Tamanini, O. Viapiana, M. Rossini, S. Adami

22-35

28-03-2013

https://doi.org/10.4081/reumatismo.2013.22

3655

PDF: 1275
Adherence to treatment and associated factors in rheumatoid arthritis patients: a cross-sectional study from Iran

D. Mohamadzadeh, S. Assar, M. Pournazari, P. Soufivand, M.S. Soleymani

08-05-2023

https://doi.org/10.4081/reumatismo.2023.1540

1675

PDF: 789
Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica

B.D. Nielsen, B. Dasgupta

1-9

27-03-2018

https://doi.org/10.4081/reumatismo.2018.1070

2203

PDF: 1577
Emerging therapies for osteoporosis

G. Minisola, A. Iuliano, I. Prevete

112-124

28-07-2014

https://doi.org/10.4081/reumatismo.2014.784

1886

PDF: 1410
Influence of TNF-α inhibition on oxidative stress of rheumatoid arthritis patients

F. Cacciapaglia, M.G. Anelli, D. Rizzo, E. Morelli, C. Scioscia, D. Mazzotta, F. Iannone, G. Lapadula

97-102

09-02-2016

https://doi.org/10.4081/reumatismo.2015.829

2233

PDF: 1298
Efficacy of bosentan in the treatment of Raynaud’s phenomenon in patients with systemic sclerosis never treated with prostanoids

S. Parisi, M. Bruzzone, C. Centanaro Di Vittorio, A. Laganà, C.L. Peroni, E. Fusaro

286-291

17-03-2014

https://doi.org/10.4081/reumatismo.2013.691

2640

PDF: 1243
Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient

C. Bruni, S. Bellando-Randone, L. Gargani, E. Picano, A. Pingitore, M. Matucci-Cerinic, S. Guiducci

109-111

09-09-2016

https://doi.org/10.4081/reumatismo.2016.889

1908

PDF: 1217
Bradykinin and its role in osteoarthritis

L. De Falco, A. Fioravanti, M. Galeazzi, S. Tenti

97-104

23-07-2013

https://doi.org/10.4081/reumatismo.2013.97

3270

PDF: 1890
The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis

A. Fassio, L. Idolazzi, M.A. Jaber, C. Dartizio, O. Viapiana, M. Rossini, D. Gatti

65-71

09-09-2016

https://doi.org/10.4081/reumatismo.2016.878

1997

PDF: 1118
Comorbidity in polymyalgia rheumatica

C. Chatzigeorgiou, S.L. Mackie

35-43

27-03-2018

https://doi.org/10.4081/reumatismo.2018.1039

3585

PDF: 2083
Pain in rheumatoid arthritis: a critical review

P. Sarzi-Puttini, F. Salaffi, M. Di Franco, L. Bazzichi, G. Cassisi, R. Casale, M. Cazzola, S. Stisi, M. Battellino, F. Atzeni

18-27

06-06-2014

https://doi.org/10.4081/reumatismo.2014.760

6117

PDF: 3605
Effectiveness of cognitive behavioral therapy in the treatment of fibromyalgia syndrome: a meta-analytic literature review

A. Minelli, A. Vaona

151-157

19-07-2012

https://doi.org/10.4081/reumatismo.2012.151

2422

PDF: 1498
Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study

L. Bazzichi, D. Biasi, E. Tinazzi, M. Muratore, R. Pellerito, R. Russo, M. Corsaro Santi, P. De Sandre, O. Epis, M. Granata, B. Kroegler, C. Meschini, F. Versace, C. Astolfi

224-232

06-11-2014

https://doi.org/10.4081/reumatismo.2014.748

2343

PDF: 1582
Intra-articular therapy with tumor necrosis factor-α antagonists: an update

S. Bello, C. Bonali, L. Serafino, C. Rotondo, N. Terlizzi, G. Lapadula

257-263

14-03-2014

https://doi.org/10.4081/reumatismo.2013.721

2603

PDF: 1248
Guidelines on prevention and treatment of vitamin D deficiency

S. Adami, E. Romagnoli, V. Carnevale, A. Scillitani, A. Giusti, M. Rossini, D. Gatti, R. Nuti, S. Minisola

129-147

09-11-2011

https://doi.org/10.4081/reumatismo.2011.129

10696

PDF: 32806
Effects of mannuronic acid (M2000) on gene expression profile of signal transducer and activator of transcription proteins (STATs) in rheumatoid arthritis patients

N.A.G. Gaafar, M. Aslani, Z. Aghazadeh, S.S. Mortazavi-Jahromi, A. Razavi, A. Mirshafiey

93-102

23-07-2020

https://doi.org/10.4081/reumatismo.2020.1235

960

PDF: 640
Neutrophil-lymphocyte ratio, pain perception, and disease activity score may serve as important predictive markers for sustained remission in rheumatoid arthritis

S. Chandrashekara, A. Rajendran, A. Bai Jaganath, R. Krishnamurthy

109-115

09-02-2016

https://doi.org/10.4081/reumatismo.2015.838

3045

PDF: 1494
A case of propylthiouracil-induced antineutrophilic cytoplasmic antibody-positive vasculitis successfully treated with radioactive iodine

C. Bes, O. Dikbaş, E. Keskin, Ö. Kaptanoğulları, M. Soy

131-133

24-07-2013

https://doi.org/10.4081/reumatismo.2013.131

2715

PDF: 694
Assessment of treatment effects on digital ulcer and blood perfusion by laser speckle contrast analysis in a patient affected by systemic sclerosis

B. Ruaro, S. Paolino, C. Pizzorni, M. Cutolo, A. Sulli

134-136

21-09-2017

https://doi.org/10.4081/reumatismo.2017.986

2424

PDF: 1053
Successful treatment of refractory adult onset Still’s disease with rituximab

N. Belfeki, M. Smiti Khanfir, F. Said, A. Hamzaoui, T. Ben Salem, I. Ben Ghorbel, M. Lamloum, M.H. Houman

159-162

16-12-2016

https://doi.org/10.4081/reumatismo.2016.888

2497

PDF: 1253
Acute colchicine overdose: report of three cases

A. Aghabiklooei, N. Zamani, H. Hassanian-Moghaddam, S. Nasouhi, M. Mashayekhian

307-311

17-03-2014

https://doi.org/10.4081/reumatismo.2013.720

4161

PDF: 1588
Cognitive-behavioral and operant-behavioral therapy for people with fibromyalgia

K. Thieme, D.C. Turk

275-285

28-09-2012

https://doi.org/10.4081/reumatismo.2012.275

3264

PDF: 3042
Glucocorticoid-induced osteoporosis: 2013 update

M. Mazzantini, O. Di Munno

144-152

28-07-2014

https://doi.org/10.4081/reumatismo.2014.787

3634

PDF: 2252
Retention rate and predictor factors of drug discontinuation in axial spondyloarthritis: a focus on certolizumab and secukinumab

Ebru Atalar, Hatice Ecem Konak, Pınar Akyüz Dağlı, Bahar Özdemir Ulusoy, Özlem Karakaş, Kevser Orhan, Rezan Koçak Ulucaköy, Esra Kayacan Erdoğan, Serdar Can Güven, Orhan Küçükşahin, İsmail Doğan, Hakan Babaoğlu, Yüksel Maraş, Şükran Erten, Ahmet Omma, Berkan Armağan

26-06-2025

https://doi.org/10.4081/reumatismo.2025.1792

1254

PDF: 2
Sarcoidosis presenting as orbital pseudotumor

S. Kobak, A. Topaloglu, G. Öncel, A. Karaarslan

78-81

16-09-2015

https://doi.org/10.4081/reumatismo.2015.832

1928

PDF: 1069
Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project

L. Dalle Carbonare, F. Bertoldo, V. Lo Cascio

54-64

https://doi.org/10.4081/reumatismo.2009.54

1275

PDF: 1074
Male osteoporosis

A. Giusti, G. Bianchi

136-143

28-07-2014

https://doi.org/10.4081/reumatismo.2014.786

2735

PDF: 1601

1 - 50 of 376 items 1 2 3 4 5 6 7 8 > >>

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy